Product Information
MECLIZINE 12.5 MG CAPLET is a generic product labeled by Rugby Laboratories, priced at $0.0313 per EA under NDC 00536129701. Its NADAC has been published 311 times since Oct 21, 2020.
Strength
12.5 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536129701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M009On Market Since
5/21/2020
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG CAPLET has been published 311 times since Oct 21, 2020, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0313 per EA |
|---|---|
| All-time high | $0.0357 (Oct 15, 2025) |
| All-time low | $0.0243 (Dec 23, 2020) |
| 52-week high | $0.0357 |
| 52-week low | $0.0294 |
| Median price | $0.0298 |
| Average price | $0.0302 |
| Largest weekly change | +17.9% (Jul 23, 2025) |
| Weeks tracked | 311 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meclizine HCl 12.5 mg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiemetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG CAPLET, manufactured by Rugby Laboratories, is $0.0313 per EA (NDC 00536129701), effective Sep 30, 2026.
How has the price of MECLIZINE 12.5 MG CAPLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG CAPLET has risen 8.4%. It has been tracked across 311 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG CAPLET?
Since Oct 21, 2020, the NADAC for MECLIZINE 12.5 MG CAPLET has ranged from a low of $0.0243 (Dec 23, 2020) to a high of $0.0357 (Oct 15, 2025), with a median of $0.0298 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG CAPLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MECLIZINE 12.5 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MECLIZINE 12.5 MG CAPLET?
MECLIZINE 12.5 MG CAPLET (NDC 00536129701) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.